O	O	0	8	Reactive	Reactive	B-NP	JJ	O	3	NMOD	O
O	O	9	15	oxygen	oxygen	I-NP	NN	O	3	NMOD	O
O	O	16	23	species	specie	I-NP	NNS	O	5	NMOD	O
O	O	24	27	and	and	I-NP	CC	O	5	NMOD	O
O	O	28	40	antioxidants	antioxidant	I-NP	NNS	O	0	ROOT	O
O	O	41	43	in	in	B-PP	IN	O	5	NMOD	O
O	O	44	56	inflammatory	inflammatory	B-NP	JJ	O	8	NMOD	O
O	O	57	65	diseases	disease	I-NP	NNS	O	6	PMOD	O
O	O	65	66	.	.	O	.	O	5	P	O

O	O	68	72	This	This	B-NP	DT	O	2	NMOD	O
O	O	73	78	paper	paper	I-NP	NN	O	3	SUB	O
O	O	79	83	aims	aim	B-VP	VBZ	O	0	ROOT	O
O	O	84	86	to	to	I-VP	TO	O	5	VMOD	O
O	O	87	93	review	review	I-VP	VB	O	3	VMOD	O
O	O	94	97	the	the	B-NP	DT	O	7	NMOD	O
O	O	98	102	role	role	I-NP	NN	O	5	OBJ	O
O	O	103	105	of	of	B-PP	IN	O	7	NMOD	O
O	O	106	110	free	free	B-NP	JJ	O	10	NMOD	O
O	O	111	118	radical	radical	I-NP	NN	O	8	PMOD	O
O	O	118	119	-	-	B-VP	HYPH	O	10	NMOD	O
O	O	119	126	induced	induce	B-NP	VBN	O	14	NMOD	O
O	O	127	133	tissue	tissue	I-NP	NN	O	14	NMOD	O
O	O	134	140	damage	damage	I-NP	NN	O	18	NMOD	O
O	O	141	144	and	and	O	CC	O	18	NMOD	O
O	O	145	156	antioxidant	antioxidant	B-NP	JJ	O	18	NMOD	O
O	O	157	164	defence	defence	I-NP	NN	O	18	NMOD	O
O	O	165	175	mechanisms	mechanism	I-NP	NNS	O	11	OBJ	O
O	O	176	178	in	in	B-PP	IN	O	18	NMOD	O
O	O	179	191	inflammatory	inflammatory	B-NP	JJ	O	21	NMOD	O
O	O	192	200	diseases	disease	I-NP	NNS	O	19	PMOD	O
O	O	201	205	that	that	B-NP	WDT	O	21	NMOD	O
O	O	206	213	involve	involve	B-VP	VBP	O	22	SBAR	O
O	O	214	224	pathogenic	pathogenic	B-NP	JJ	O	25	NMOD	O
O	O	225	234	processes	process	I-NP	NNS	O	23	OBJ	O
O	O	235	242	similar	similar	B-ADJP	JJ	O	25	NMOD	O
O	O	243	245	to	to	B-PP	TO	O	26	AMOD	O
O	O	246	249	the	the	B-NP	DT	O	30	NMOD	O
O	O	250	261	periodontal	periodontal	I-NP	JJ	O	30	NMOD	O
O	O	262	270	diseases	disease	I-NP	NNS	O	27	PMOD	O
O	O	270	271	.	.	O	.	O	3	P	O

O	O	272	277	There	There	B-NP	EX	O	2	SUB	O
O	O	278	280	is	be	B-VP	VBZ	O	25	VMOD	O
O	O	281	282	a	a	B-NP	DT	O	8	NMOD	O
O	O	283	290	clearly	clearly	I-NP	RB	O	5	AMOD	O
O	O	291	298	defined	define	I-NP	VBN	O	7	AMOD	O
O	O	299	302	and	and	I-NP	CC	O	7	AMOD	O
O	O	303	314	substantial	substantial	I-NP	JJ	O	8	NMOD	O
O	O	315	319	role	role	I-NP	NN	O	2	PRD	O
O	O	320	323	for	for	B-PP	IN	O	8	NMOD	O
O	O	324	328	free	free	B-NP	JJ	O	11	NMOD	O
O	O	329	337	radicals	radical	I-NP	NNS	O	15	NMOD	O
O	O	338	340	or	or	O	CC	O	15	NMOD	O
O	O	341	349	reactive	reactive	B-NP	JJ	O	15	NMOD	O
O	O	350	356	oxygen	oxygen	I-NP	NN	O	15	NMOD	O
O	O	357	364	species	specie	I-NP	NNS	O	9	PMOD	O
O	O	365	366	(	(	O	(	O	18	DEP	O
O	O	366	369	ROS	ROS	B-NP	NNS	O	18	DEP	O
O	O	369	370	)	)	O	)	O	15	NMOD	O
O	O	371	373	in	in	B-PP	IN	O	8	NMOD	O
O	O	374	387	periodontitis	periodontitis	B-NP	NN	O	19	PMOD	O
O	O	387	388	,	,	O	,	O	25	P	O
O	O	389	392	but	but	O	CC	O	25	VMOD	O
O	O	393	399	little	little	B-NP	JJ	O	24	NMOD	O
O	O	400	408	research	research	I-NP	NN	O	25	SUB	O
O	O	409	412	has	have	B-VP	VBZ	O	0	ROOT	O
O	O	413	417	been	be	I-VP	VBN	O	25	VC	O
O	O	418	427	performed	perform	I-VP	VBN	O	26	VC	O
O	O	428	430	in	in	B-PP	IN	O	27	VMOD	O
O	O	431	435	this	this	B-NP	DT	O	30	NMOD	O
O	O	436	440	area	area	I-NP	NN	O	28	PMOD	O
O	O	440	441	.	.	O	.	O	25	P	O

O	O	442	446	This	This	B-NP	DT	O	2	NMOD	O
O	O	447	452	paper	paper	I-NP	NN	O	3	SUB	O
O	O	453	460	reviews	review	B-VP	VBZ	O	0	ROOT	O
O	O	461	464	the	the	B-NP	DT	O	6	NMOD	O
O	O	465	477	considerable	considerable	I-NP	JJ	O	6	NMOD	O
O	O	478	482	data	datum	I-NP	NNS	O	3	OBJ	O
O	O	483	492	available	available	B-ADJP	JJ	O	6	NMOD	O
O	O	493	501	relating	relate	B-VP	VBG	O	6	NMOD	O
O	O	502	505	ROS	ROS	B-NP	NN	O	10	NMOD	O
O	O	506	514	activity	activity	I-NP	NN	O	13	NMOD	O
O	O	515	518	and	and	O	CC	O	13	NMOD	O
O	O	519	530	antioxidant	antioxidant	B-NP	JJ	O	13	NMOD	O
O	O	531	538	defence	defence	I-NP	NN	O	8	OBJ	O
O	O	539	541	to	to	B-PP	TO	O	13	NMOD	O
O	O	542	554	inflammatory	inflammatory	B-NP	JJ	O	16	NMOD	O
O	O	555	563	diseases	disease	I-NP	NNS	O	14	PMOD	O
O	O	564	567	and	and	O	CC	O	3	VMOD	O
O	O	568	576	attempts	attempt	B-NP	NNS	O	3	VMOD	O
O	O	577	579	to	to	B-VP	TO	O	20	VMOD	O
O	O	580	584	draw	draw	I-VP	VB	O	18	VMOD	O
O	O	585	594	parallels	parallel	B-NP	NNS	O	20	OBJ	O
O	O	595	599	with	with	B-PP	IN	O	21	NMOD	O
O	O	600	613	periodontitis	periodontitis	B-NP	NN	O	22	PMOD	O
O	O	613	614	,	,	O	,	O	18	P	O
O	O	615	617	in	in	B-PP	IN	O	18	NMOD	O
O	O	618	620	an	an	B-NP	DT	O	27	NMOD	O
O	O	621	627	effort	effort	I-NP	NN	O	25	PMOD	O
O	O	628	630	to	to	B-VP	TO	O	29	VMOD	O
O	O	631	640	stimulate	stimulate	I-VP	VB	O	27	NMOD	O
O	O	641	645	more	more	B-NP	RBR	O	31	AMOD	O
O	O	646	657	periodontal	periodontal	I-NP	JJ	O	32	NMOD	O
O	O	658	666	research	research	I-NP	NN	O	29	OBJ	O
O	O	667	669	in	in	B-PP	IN	O	29	VMOD	O
O	O	670	674	this	this	B-NP	DT	O	36	NMOD	O
O	O	675	684	important	important	I-NP	JJ	O	36	NMOD	O
O	O	685	689	area	area	I-NP	NN	O	33	PMOD	O
O	O	689	690	.	.	O	.	O	3	P	O

O	O	691	694	The	The	B-NP	DT	O	3	NMOD	O
O	O	695	701	recent	recent	I-NP	JJ	O	3	NMOD	O
O	O	702	711	discovery	discovery	I-NP	NN	O	18	SUB	O
O	O	712	714	of	of	B-PP	IN	O	3	NMOD	O
O	O	715	718	the	the	B-NP	DT	O	7	NMOD	O
T6	B-Entity	719	732	transcription	transcription	I-NP	NN	B-protein	7	NMOD	B-protein
T6	I-Entity	733	739	factor	factor	I-NP	NN	I-protein	11	NMOD	I-protein
T6	I-Entity	740	747	nuclear	nuclear	B-NP	JJ	B-protein	11	NMOD	B-protein
T6	I-Entity	748	754	factor	factor	I-NP	NN	I-protein	11	NMOD	I-protein
T6	I-Entity	755	760	kappa	kappa	I-NP	NN	I-protein	11	NMOD	I-protein
T6	I-Entity	761	762	B	B	I-NP	NN	I-protein	4	PMOD	I-protein
O	O	763	764	(	(	O	(	O	17	DEP	O
T7	B-Entity	764	766	NF	NF	B-NP	NN	B-protein	16	NMOD	B-protein
T7	I-Entity	766	767	-	-	B-NP	HYPH	I-protein	16	NMOD	I-protein
T7	I-Entity	767	772	kappa	kappa	I-NP	NN	I-protein	16	NMOD	I-protein
T7	I-Entity	773	774	B	B	I-NP	NN	I-protein	17	DEP	I-protein
O	O	774	775	)	)	O	)	O	11	NMOD	O
O	O	776	778	is	be	B-VP	VBZ	O	38	VMOD	O
O	O	779	787	reviewed	review	I-VP	VBN	O	18	VC	O
O	O	788	791	and	and	O	CC	O	38	VMOD	O
O	O	792	799	several	several	B-NP	JJ	O	23	NMOD	O
O	O	800	809	potential	potential	I-NP	JJ	O	23	NMOD	O
O	O	810	818	pathways	pathway	I-NP	NNS	O	38	SUB	O
O	O	819	822	for	for	B-PP	IN	O	23	NMOD	O
O	O	823	831	cytokine	cytokine	B-NP	NN	B-protein	30	NMOD	B-protein
O	O	831	832	-	-	B-NP	HYPH	O	30	NMOD	O
O	O	832	839	induced	induce	I-NP	VBN	O	30	NMOD	O
O	O	840	851	periodontal	periodontal	I-NP	JJ	O	30	NMOD	O
O	O	852	858	tissue	tissue	I-NP	NN	O	30	NMOD	O
O	O	859	865	damage	damage	I-NP	NN	O	24	PMOD	O
O	O	865	866	,	,	O	,	O	23	P	O
O	O	867	875	mediated	mediate	B-VP	VBN	O	23	NMOD	O
O	O	876	878	by	by	B-PP	IN	O	32	VMOD	O
T1	B-Protein	879	881	NF	NF	B-NP	NN	B-protein	37	NMOD	B-protein
T1	I-Protein	881	882	-	-	I-NP	HYPH	I-protein	37	NMOD	I-protein
T1	I-Protein	882	887	kappa	kappa	I-NP	NN	I-protein	37	NMOD	I-protein
T1	I-Protein	888	890	B1	B1	I-NP	NN	I-protein	33	PMOD	I-protein
O	O	891	894	are	be	B-VP	VBP	O	0	ROOT	O
O	O	895	904	discussed	discuss	I-VP	VBN	O	38	VC	O
O	O	904	905	.	.	O	.	O	38	P	O

O	O	906	914	Emphasis	Emphasis	B-NP	NN	O	2	SUB	O
O	O	915	917	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	918	924	placed	place	I-VP	VBN	O	2	VC	O
O	O	925	927	on	on	B-PP	IN	O	3	VMOD	O
O	O	928	937	cytokines	cytokine	B-NP	NNS	B-protein	32	NMOD	B-protein
O	O	938	942	that	that	B-NP	WDT	O	32	NMOD	O
O	O	943	947	have	have	B-VP	VBP	O	6	SBAR	O
O	O	948	952	been	be	I-VP	VBN	O	7	VC	O
O	O	953	960	studied	study	I-VP	VBN	O	8	VC	O
O	O	961	963	in	in	B-PP	IN	O	9	VMOD	O
O	O	964	977	periodontitis	periodontitis	B-NP	NN	O	10	PMOD	O
O	O	977	978	,	,	O	,	O	30	P	O
O	O	979	990	principally	principally	B-NP	RB	O	30	NMOD	O
T2	B-Protein	991	994	TNF	TNF	I-NP	NN	B-protein	30	NMOD	B-protein
T2	I-Protein	994	995	-	-	O	HYPH	O	30	P	O
T2	I-Protein	995	1000	alpha	alpha	B-NP	SYM	O	19	NMOD	O
O	O	1000	1001	,	,	O	,	O	19	P	O
O	O	1002	1004	IL	IL	B-NP	NN	B-protein	19	NMOD	B-protein
O	O	1004	1005	-	-	B-NP	HYPH	I-protein	30	P	I-protein
O	O	1005	1006	1	1	I-NP	CD	I-protein	19	NMOD	I-protein
O	O	1006	1007	,	,	O	,	O	19	P	O
T3	B-Protein	1008	1010	IL	IL	B-NP	NN	B-protein	23	NMOD	B-protein
T3	I-Protein	1010	1011	-	-	O	HYPH	I-protein	19	P	I-protein
T3	I-Protein	1011	1012	6	6	B-NP	CD	I-protein	19	NMOD	I-protein
O	O	1012	1013	,	,	O	,	O	19	P	O
T4	B-Protein	1014	1016	IL	IL	B-NP	NN	B-protein	27	NMOD	B-protein
T4	I-Protein	1016	1017	-	-	I-NP	HYPH	I-protein	30	P	I-protein
T4	I-Protein	1017	1018	8	8	I-NP	CD	I-protein	27	NMOD	I-protein
O	O	1019	1022	and	and	O	CC	O	30	NMOD	O
T5	B-Protein	1023	1027	beta	beta	B-NP	SYM	O	32	NMOD	O
T5	I-Protein	1027	1028	-	-	O	HYPH	O	32	P	O
T5	I-Protein	1028	1038	interferon	interferon	B-NP	NN	B-protein	4	PMOD	B-protein
O	O	1038	1039	.	.	O	.	O	2	P	O

O	O	1040	1043	The	The	B-NP	DT	O	2	NMOD	O
O	O	1044	1048	link	link	I-NP	NN	O	28	SUB	O
O	O	1049	1056	between	between	B-PP	IN	O	2	NMOD	O
O	O	1057	1065	cellular	cellular	B-NP	JJ	O	5	NMOD	O
O	O	1066	1076	production	production	I-NP	NN	O	14	NMOD	O
O	O	1077	1079	of	of	B-PP	IN	O	5	NMOD	O
O	O	1080	1084	such	such	B-NP	JJ	O	8	AMOD	O
O	O	1085	1094	important	important	I-NP	JJ	O	9	NMOD	O
O	O	1095	1104	mediators	mediator	I-NP	NNS	O	6	PMOD	O
O	O	1105	1107	of	of	B-PP	IN	O	9	NMOD	O
O	O	1108	1120	inflammation	inflammation	B-NP	NN	O	10	PMOD	O
O	O	1121	1124	and	and	O	CC	O	14	NMOD	O
O	O	1125	1128	the	the	B-NP	DT	O	14	NMOD	O
O	O	1129	1140	antioxidant	antioxidant	I-NP	NN	O	23	NMOD	O
O	O	1141	1142	(	(	O	(	O	17	DEP	O
O	O	1142	1144	AO	AO	B-NP	NN	O	17	DEP	O
O	O	1144	1145	)	)	O	)	O	14	NMOD	O
O	O	1146	1152	thiols	thiol	B-NP	NNS	O	14	NMOD	O
O	O	1152	1153	,	,	O	,	O	23	P	O
T8	B-Entity	1154	1162	cysteine	cysteine	B-NP	NN	O	23	NMOD	O
O	O	1163	1166	and	and	O	CC	O	23	NMOD	O
T9	B-Entity	1167	1174	reduced	reduce	B-NP	VBN	O	23	NMOD	O
T9	I-Entity	1175	1186	glutathione	glutathione	I-NP	NN	O	3	PMOD	O
O	O	1187	1188	(	(	O	(	O	26	DEP	O
T10	B-Entity	1188	1191	GSH	GSH	B-NP	NN	O	26	DEP	O
O	O	1191	1192	)	)	O	)	O	23	NMOD	O
O	O	1192	1193	,	,	O	,	O	28	P	O
O	O	1194	1196	is	be	B-VP	VBZ	O	32	VMOD	O
O	O	1197	1206	discussed	discuss	I-VP	VBN	O	28	VC	O
O	O	1207	1210	and	and	O	CC	O	32	VMOD	O
O	O	1211	1213	it	it	B-NP	PRP	O	32	SUB	O
O	O	1214	1216	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	1217	1229	hypothesised	hypothesise	I-VP	VBN	O	32	VC	O
O	O	1230	1234	that	that	B-SBAR	IN	O	33	VMOD	O
T11	B-Entity	1235	1237	NF	NF	B-NP	NN	B-protein	39	NMOD	B-protein
T11	I-Entity	1237	1238	-	-	B-NP	HYPH	I-protein	39	NMOD	I-protein
T11	I-Entity	1238	1243	kappa	kappa	I-NP	NN	I-protein	39	NMOD	I-protein
T11	I-Entity	1244	1245	B	B	I-NP	NN	I-protein	39	NMOD	I-protein
O	O	1246	1257	antagonists	antagonist	I-NP	NNS	O	40	SUB	O
O	O	1258	1261	may	may	B-VP	MD	O	34	SBAR	O
O	O	1262	1267	offer	offer	I-VP	VB	O	40	VC	O
O	O	1268	1277	important	important	B-NP	JJ	O	43	AMOD	O
O	O	1278	1289	therapeutic	therapeutic	I-NP	JJ	O	44	NMOD	O
O	O	1290	1298	benefits	benefit	I-NP	NNS	O	41	OBJ	O
O	O	1298	1299	.	.	O	.	O	32	P	O
